Docetaxel

Land: New Zealand

Sprog: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv bestanddel:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Tilgængelig fra:

REX Medical Ltd

INN (International Name):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Dosering:

80 mg/mL

Lægemiddelform:

Concentrate for infusion

Sammensætning:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Enheder i pakken:

Vial, glass, Diluent, 6 mL

Klasse:

Prescription

Recept type:

Prescription

Fremstillet af:

Cipla Ltd

Terapeutiske indikationer:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Produkt oversigt:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Autorisation dato:

2006-06-23